CFO4Life Group’s Tenet Healthcare THC Stock Holding History

CFO4Life Group’s Portfolio THC Stock Details THC Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2025 Q1	–	Sell	-2,479	Closed	-$313K	–	237
2024 Q4	$313K	Buy	+2,479	New	+$369K	0.06%	151

Other funds holding THC

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return

T. Rowe Price Associates Baltimore, Maryland $865B AUM 30.76% 1-Year Est. Return

Invesco Atlanta, Georgia $1.02T AUM 30.18% 1-Year Est. Return

GCM

Glenview Capital Management New York $3.98B AUM 20.52% 1-Year Est. Return

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return

Ameriprise Minneapolis, Minnesota $432B AUM 30.22% 1-Year Est. Return

Citadel Advisors Miami, Florida $618B AUM 30.34% 1-Year Est. Return

CFO4Life Group's THC Position: Q1 2025 in Review

CFO4Life Group sold out of Tenet Healthcare (THC) in Q1 2025, closing a stake of 2,479 shares — an estimated $313K sold.

CFO4Life Group first reported a position in THC in Q4 2024 and held it in 1 quarter. The position peaked at $313K in Q4 2024. 566 funds tracked by Wall St. Rank hold THC as of Q1 2025.

CFO4Life Group reported no remaining Tenet Healthcare position as of Q1 2025 after selling out during the quarter.
CFO4Life Group sold 2,479 Tenet Healthcare shares in Q1 2025, an estimated $313K.
CFO4Life Group first reported a position in Tenet Healthcare in Q4 2024 and held it in 1 quarter.
CFO4Life Group's Tenet Healthcare position peaked at $313K in Q4 2024.
566 funds tracked by Wall St. Rank held Tenet Healthcare as of Q1 2025.

Based on CFO4Life Group's 13F filing for Q1 2025, filed 30 Apr 2025.